US · Healthcare · Health Information Services
EPS came in at 0.04 against a street estimate of 0.04 — a beat of 0.0%.
Analysts rate Goodrx Holdings Inc a buy (8 buy, 7 hold, 1 sell out of 16) with an average price target of $4.03.
| Fund | Stake |
|---|---|
| Francisco Partners Management LP | 17.61% |
| LSV Asset Management | 1.51% |
| Ameriprise Financial Inc | 1.31% |
| Vanguard Capital Management, LLC | 1.25% |
| SILVER LAKE GROUP, L.L.C. | 1.04% |
| Vanguard Portfolio Management, LLC | 0.99% |
| Renaissance Technologies Corp | 0.96% |
| Petrus Trust Company, LTA | 0.91% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 GOODRX HOLDINGS, INC. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue (Q2 2026): $200.4 million; down slightly from $203.1 million in Q2 2025 • Re | 2026-08-05 |
| Board / officer change · Q3 2026 GOODRX HOLDINGS, INC. - FORM 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Christopher McGinnis transitioned out of his role as Chief Financial Office | 2026-08-05 |
| Results announced · Q3 2026 GOODRX Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 2026 Revenue: $200.4 million (down 1% YoY from $203.1 million) • Net Income: $8.5 million wit | 2026-08-05 |
| Shareholder vote results · Q2 2026 GOOFRX HOLDINGS, INC. - STOCKHOLDER MEETING SUMMARY HEADLINE NUMBERS • Annual stockholders meeting held June 16, 2026 • 99.4% of combined voting pow | 2026-06-18 |
| Quarterly report · Q1 2026 GOODRX HOLDINGS, INC. — Q1 2026 SUMMARY HEADLINE NUMBERS • Revenue Q1 2026: $194.0 million (down 4.4% vs. Q1 2025: $203.0 million) • Net Income Q1 2 | 2026-05-06 |
| Results announced · Q2 2026 GOODRX Q1 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Total Revenue: $194.0 million, down 4% year-over-year from $203.0 million • Net Income: $1.2 mil | 2026-05-06 |
| Proxy statement · Q4 2025 GOODRX HOLDINGS, INC. — 2026 PROXY SUMMARY --- WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of Directors — Vote to elect three Class III | 2026-04-29 |
| Annual report FY2025 GOODRX HOLDINGS, INC. – FORM 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Fiscal year ended December 31, 2025 • Public company trading on Na | 2026-02-26 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Goodrx Holdings Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.